NuVasive Vuepoint Oct System
Appliance, Fixation, Spinal Interlaminal. 510(k) K093319, from Nuvasive, Inc. (San Diego, CA). Product code KWP, class 2.
As of Nov 19, 2026, K093319 is an FDA 510(k) held by Nuvasive, Inc., substantially equivalent on Jun 23, 2010 after 243 days, with no recalls tied to it in FDA's recall database.
- Review time: 243 days
- Recalls: 0
- Cited as a predicate by: 6 devices
The VuePoint® OCT System is intended to promote fusion of the cervical spine and occipito-thoracic junction (Occiput-T3), and is indicated for: (1) Degenerative disc disease (as defined by back pain of discogenic origin with degeneration of the disc confirmed by patient history and radiographic studies), (2) Degenerative spondylolisthesis with objective evidence of neurologic impairment, (3)…
- NuVasive Oct SystemK071435 · Nuvasive, Inc. · Aug 6, 2007
- NuVasive Spherx Ii - Pedicle Screw SystemK092287 · Nuvasive, Inc. · Oct 6, 2009
- Mountaineer Oct Spinal SystemK080828 · Depuy Spine, Inc. · Jun 27, 2008
- NuVasive Reline Cervical SystemK213654 · Nu Vasive, Incorporated · Feb 23, 2022
- Invictus™ OCT Spinal Fixation SystemK203125 · Alphatec Spine, Inc. · Dec 18, 2020
- NuVaisve® Reline® Cervical SystemK191553 · Nu Vasive, Incorporated · Aug 14, 2019
- NuVasive® VuePoint® II OCT SystemK180198 · Nu Vasive, Incorporated · Mar 15, 2018
- VuePoint OCT SystemK153336 · Nu Vasive, Incorporated · Jan 7, 2016
- Streamline Oct Occipito-Cervico-Thoracic SystemK133374 · Pioneer Surgical Technology, Inc. (Rti Surgical, I · Mar 19, 2014
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Oct 23, 2009
- Review panel
- Orthopedic
- Regulation
- 21 CFR 888.3050
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files